<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sri Hidanah</style></author><author><style face="normal" font="default" size="100%">Emy Koestanti Sabdoningrum</style></author><author><style face="normal" font="default" size="100%">Sri Agus Sudjarwo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Formulation and Characterization of Meniran (Phyllanthus Niruri Linn) Extract Nanoparticle on Antibacterial Activity Against Salmonella Pullorum</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Nanoparticle</style></keyword><keyword><style  face="normal" font="default" size="100%">Phyllanthus niruri</style></keyword><keyword><style  face="normal" font="default" size="100%">Salmonella Pullorum</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">369-373</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;This study aims to examine the results of meniran extract (&lt;em&gt;Phyllanthus niruri Linn.&lt;/em&gt;) on antibacterial activity. &lt;em&gt;Salmonella Pullorum&lt;/em&gt; is capable of causing huge economic losses. The misuse of antimicrobials has resulted in the evolution of multidrug-resistant strains. Meniran has potential as an antibacterial because it contains many bioactive components such as alkaloids, flavonoids, tannins and saponins. Nanoparticles help in the bioavailability of plant extracts. The research was conducted by making a meniran extract nanoparticles formulation with ionic glass method using chitosan and TPP sodium with a dose difference of 5%, 10% and 20%. Each dose of meniran nanoparticles then were characterized by PSA, SEM and TEM. The result on PSA showed that size range from 192.67 nm to 385.16 nm and 5% meniran extract nanoparticles have the best homogeneity and stability. EE value showed that the increase in the dose was directly proportional to the increase in the EE value. The result on SEM showed that the overall production of nanoparticle samples, it looks like they are nano-sized. The result on TEM showed small sample morphology with a good distribution. After that, the antibacterial activity test was then carried out using the MIC and MBC tests. The results showed that 5% of meniran extract nanoparticles had the best antibacterial activity against Salmonella Pullorum.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">369</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Sri Hidanah, Emy Koestanti Sabdoningrum*, Sri Agus Sudjarwo&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mohammad Sukmanadi</style></author><author><style face="normal" font="default" size="100%">Sri Agus Sudjarwo</style></author><author><style face="normal" font="default" size="100%">Mustofa Helmi Effendi</style></author><author><style face="normal" font="default" size="100%">Pudji Srianto</style></author><author><style face="normal" font="default" size="100%">Aulanni’am</style></author><author><style face="normal" font="default" size="100%">Rr Sri Pantja Madyawati</style></author><author><style face="normal" font="default" size="100%">Mirni Lamid</style></author><author><style face="normal" font="default" size="100%">Hani Plumeriastuti</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Capsaicin Bioactive in Cabai (Capsicum Annum L.) as Anticancer Through Inhibition of over Ekspresi Protein Target RAC-alpha serine/threonine-protein kinase (AKT1) and Mitogen-activated protein kinase 1 (MAPK1) on Hepatocyt Cell Mice (mus musculus)</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AKT1</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Capsaicin</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatocellular carcinoma (HCC)</style></keyword><keyword><style  face="normal" font="default" size="100%">MAPK1</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">911-915</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Capsaicin is a secondary metabolite of the Chilean plant. In the pharmaceutical field in addition to relieving pain or pain, capsaicin is also known to have anticancer activity because it inhibits certain oncogenic proteins. Screening of components in &lt;em&gt;Capsicum Annum&lt;/em&gt; L. against the target proteins AKT1 and MAPK1 is needed as an initial stage of drug discovery. Further screening of Capsaicin compounds for oncogenic proteins produced in Hepatocellular carcinoma (HCC) pathogenesis signaling. In silico data that have been obtained, Capsaicin in chili (&lt;em&gt;Capsicum Annum&lt;/em&gt; L.) has a high affinity for MAPK1 and AKT1 receptor/protein targets with energy and potential activity score (Pa) 0.690 for preneoplastic treatment, 0.590 for apoptotic agonists, and 0.366 for antineoplastic activity. Statistical data using Kruskal Wallis obtained information that Capsaicin can inhibit the expression of AKT 1 and MAPK 1 on mice hepatocyte cells induced by AFB1 &lt;em&gt;in vivo &lt;/em&gt;administration, therefore it can be a candidate for anticancer drugs.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">911</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Mohammad Sukmanadi&lt;sup&gt;1,&lt;/sup&gt;*, Sri Agus Sudjarwo&lt;sup&gt;2&lt;/sup&gt;, Mustofa Helmi Effendi&lt;sup&gt;3&lt;/sup&gt;, Pudji Srianto&lt;sup&gt;4&lt;/sup&gt;, Aulanni’am&lt;sup&gt;5&lt;/sup&gt;, Rr. Sri Pantja Madyawati&lt;sup&gt;4&lt;/sup&gt;, Mirni Lamid&lt;sup&gt;6&lt;/sup&gt;, Hani Plumeriastuti&lt;sup&gt;7&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Student, Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Basic Veterinary Medicine, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Veterinary Public Health, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Reproductions Veteriner, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Faculty of Veterinary Medicine, Universitas Brawijaya, Malang, 651455, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Department of Animal Husbandry, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Department of Patology Veteriner, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mohammad Sukmanadi</style></author><author><style face="normal" font="default" size="100%">Sri Agus Sudjarwo</style></author><author><style face="normal" font="default" size="100%">Mustofa Helmi Effendi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Molecular Mechanism of Capsaicin from (Capsicum Annuum L.) on Expression of MAPK1 and AKT1 Protein as Candidate of Anticancer Drugs: In silico Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AKT1</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Capsaicin</style></keyword><keyword><style  face="normal" font="default" size="100%">Capsicum annuum L.</style></keyword><keyword><style  face="normal" font="default" size="100%">MAPK1</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">916-919</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;One of the most important compounds in &lt;em&gt;Capsicum annuum&lt;/em&gt; L. is capsaicin, capsaicin is a secondary metabolite of the &lt;em&gt;Capsicum Annuum&lt;/em&gt; L. plant. In the pharmaceutical field in addition to relieving pain or pain, capsaicin is also known to have anticancer activity because it inhibits certain oncogenic proteins. Further screening of the capsaicin compound against the oncogenic protein produced in the HCC pathogenesis signaling is needed. Screening components in &lt;em&gt;Capsicum annuum&lt;/em&gt; L. against MAPK1 and AKT1 target proteins is the initial stage of drug discovery. MAPK1 and AKT1 protein bundles and capsaicin ligand bundles that were prepared previously in Autodock 4.0 were molecular dockings (molecular docking). After molecular docking, it was found that capsaicin binds to MAPK1 / ERK with the free energy of Gibbs of -5.5 Kcal/mol and AKT1 of -6.7 Kcal/mol. The free energy of Gibbs is so negative that it is ensured that the reaction will take place spontaneously and lead to high affinity. The data that has been obtained, capsaicin in &lt;em&gt;Capsicum annuum&lt;/em&gt; L. has a high affinity for MAPK1 and AKT1 receptor/protein targets with the binding energy of -5.5 Kcal/mol and -6.7 Kcal/ mol and Potential Activity Score (Pa ) equal to 0,690 for preneoplastic treatment, 0.590 for apoptosis agonist, and 0.366 for antineoplastic activity and accordingly become candidates for anticancer drugs.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">916</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Mohammad Sukmanadi&lt;sup&gt;1,&lt;/sup&gt;*, Sri Agus Sudjarwo&lt;sup&gt;2&lt;/sup&gt;, Mustofa Helmi Effendi&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Student, Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Basic Veterinary Medicine, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Veterinary Public Health, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Giftania Wardani</style></author><author><style face="normal" font="default" size="100%">Mahmiah</style></author><author><style face="normal" font="default" size="100%">Sri Agus Sudjarwo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Immunostimulatory Activity of Chitosan Nanoparticles on Wistar Albino Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chitosan nanoparticle</style></keyword><keyword><style  face="normal" font="default" size="100%">Delayed-Type Hypersensitivity</style></keyword><keyword><style  face="normal" font="default" size="100%">Haemagglutinating antibody</style></keyword><keyword><style  face="normal" font="default" size="100%">Myelosuppression</style></keyword><keyword><style  face="normal" font="default" size="100%">Neutrophil adhesion</style></keyword><keyword><style  face="normal" font="default" size="100%">Phagocytosis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">892-898</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; The active components of natural products provide a potential alternative to conventional immunotherapy for a variety of diseases conditions and become subject to scientific investigations currently worldwide. &lt;strong&gt;Objective:&lt;/strong&gt; The purpose of this research was to investigate the immunostimulatory activity of the chitosan nanoparticle on Wistar albino rats.&lt;strong&gt; Materials and Methods:&lt;/strong&gt; The present investigation was carried out on various groups of healthy adult rats. The assessment of immunomodulatory potential was carried out by neutrophil adhesion test, delayed-type hypersensitivity (DTH) response, haemagglutinating antibody (HA) titre, cyclophosphamide-induced myelosuppression and phagocytic activity were determined in various groups of animals. &lt;strong&gt;Results:&lt;/strong&gt; The administration of chitosan nanoparticle at doses 300 mg/kg BW and 600 mg/kg BW but not at doses 150 mg/kg BW significantly increased in neutrophil adhesion fibers, haemagglutinating antibody titre values and potentiated the inhibited type hypersensitivity reaction induced by sheep red blood cells. Also, it had good response towards phagocytosis in carbon clearance assay and prevented myelosuppression of cyclophosphamide on rats. &lt;strong&gt;Conclusion:&lt;/strong&gt; From these findings, it can be concluded that chitosan nanoparticle responsible for immunostimulatory activity and has therapeutic potential for the prevention of immune depressed conditions.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">892</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Giftania Wardani&lt;sup&gt;1&lt;/sup&gt;, Mahmiah&lt;sup&gt;1&lt;/sup&gt;, Sri Agus Sudjarwo&lt;sup&gt;2&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt; 1&lt;/sup&gt;Department of Pharmacy Biology, Faculty of Pharmacy, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Faculty of Veterinary Medicine, Airlangga University, Surabaya 60115, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Giftania Wardani</style></author><author><style face="normal" font="default" size="100%">Mahmiah</style></author><author><style face="normal" font="default" size="100%">Sri Agus Sudjarwo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Antibacterial Activity of Chitosan Nanoparticles against Mycobacterium tuberculosis</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chitosan nanoparticle</style></keyword><keyword><style  face="normal" font="default" size="100%">M. tuberculosis H37Rv</style></keyword><keyword><style  face="normal" font="default" size="100%">Minimal bactericidal concentration.</style></keyword><keyword><style  face="normal" font="default" size="100%">Minimal inhibitory Concentration</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/413</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">162-166</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Chitosan nanoparticles have gained growing interest for nanomedicine, biomedical engineering and development of new therapeutic with improved bioavailability, increased sensitivity and specificity, and reduced toxicity. &lt;strong&gt;Objective:&lt;/strong&gt; The aim of the present study is to synthesis of the chitosan nanoparticles for antimycobacterial applications. &lt;strong&gt;Methods:&lt;/strong&gt; Chitosan were isolated from the shrimp shell. Tripolyphosphate (TPP) will be used to prepare chitosan nanoparticles by ionotropic gelation method. The size and morphology of the chitosan nanoparticle was analyzed by scanning electron microscope (SEM). The broth microdilution method is used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of nanoparticle chitosan on strain &lt;em&gt;M. tuberculosis&lt;/em&gt; H37Rv. &lt;strong&gt;Results:&lt;/strong&gt; The SEM micrographs of the nano-magnetic chitosan showed that they were approximately uniform spheres and the rough surface morphology, have a solid dense cubical or rectangular structure. Using the broth microdilution susceptibility method, chitosan nanoparticle was found to have the antimycobacterial effects with a MIC value of 1200 &amp;mu;g/mL whilst MBCs value of 2400 &amp;mu;g/mL for &lt;em&gt;M. tuberculosis&lt;/em&gt; H37Rv. Conclusion: The conclusion from the study was chitosan nanoparticle have potential as a source of lead compounds that may be developed further into antimycobacterial drugs.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">162</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Giftania Wardani&lt;sup&gt;1&lt;/sup&gt;, Mahmiah&lt;sup&gt;1&lt;/sup&gt;, Sri Agus Sudjarwo&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacy Biology, Faculty of Pharmacy, Hang Tuah University, Surabaya, INDONESIA.&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Faculty of Veterinary Medicine, Airlangga University, Surabaya-60115, INDONESIA.&lt;/p&gt;</style></auth-address></record></records></xml>